With an in-depth exploration of the interplay between chemokine and ANGPT1, our work may provide valuable insights into the regulatory network of vascular normalization, offering new avenues for modulating tumor microenvironment and overcoming resistance to anti-angiogenesis therapy in lung adenocarcinoma treatment. The gene discussed is ANGPT1; the disease is lung adenocarcinoma.